New study suggests mRNA Covid vaccines may boost cancer immunotherapy response

A study in Nature Medicine on 10 September looked at records of 95,015 adults on immunotherapy in France.
Those vaccinated with mRNA within 100 days before immunotherapy had a lower risk of death.
The association weakened after 12 months, suggesting the effect may not last.
Experts say clinical trials are needed before any link can be established.

Get 100 stories a day on the app Read, watch & listen · Free on iOS & Android

Older